000			04836nam a22003975i 4500
001			289525
003			MX-SnUAN
005			20160429154713.0
007			cr nn 008mamaa
008			150903s2005 xxu| o |||| 0|eng d
020			_a9781592597642 _99781592597642
024	7		_a10.1385/1592597645 _2doi
035			_avtls000342795
039		9	_a201509030224 _bVLOAD _c201405070519 _dVLOAD _y201402061135 _zstaff
040			_aMX-SnUAN _bspa _cMX-SnUAN _erda
050		4	_aRC109-216
100	1		_aLindler, Luther E. _eeditor. _9319784
245	1	0	_aBiological Weapons Defense : _bInfectious Diseases and Counterbioterrorism / _cedited by Luther E. Lindler, Frank J. Lebeda, George W. Korch.
264		1	_aTotowa, NJ : _bHumana Press, _c2005.
300			_brecurso en línea.
336			_atexto _btxt _2rdacontent
337			_acomputadora _bc _2rdamedia
338			_arecurso en línea _bcr _2rdacarrier
347			_aarchivo de texto _bPDF _2rda
490	0		_aInfectious Disease
500			_aSpringer eBooks
505	0		_aPreparation and Military Support for a Possible Bioterrorism Incident -- Department of Defense Capabilities Supporting Bioterrorism Response -- Modeling for Bioterrorism Incidents -- Biological Weapons Defense -- Medical Countermeasures and Decontamination -- Pathogenesis by Aerosol -- Bacillus anthracis and the Pathogenesis of Anthrax -- Virologic and Pathogenic Aspects of the Variola Virus (Smallpox) as a Bioweapon -- Plague Vaccines -- Medical Protection Against Brucellosis -- Pathogenesis of and Immunity to Coxiella burnetii -- Glanders -- Medical Countermeasures for Filoviruses and Other Viral Agents -- Medical Defense Against Protein Toxin Weapons -- Antimicrobials for Biological Warfare Agents -- Nonspecific Immunomodulator Therapy -- Decontamination -- Emerging Threats and Future Preparation -- Definition and Overview of Emerging Threats -- Department of Defense Global Emerging Infections System Programs in Biodefense -- Information Resources and Database Development for Defense Against Biological Weapons -- Genomic Efforts With Biodefense Pathogens -- Genomics for Biodefense -- Genetic Fingerprinting of Biodefense Pathogens for Epidemiology and Forensic Investigation -- Yersinia pestis as an Emerged Pathogen -- Diagnostic Development for Biowarfare Agents -- Requirements for Biological Threat Identification Systems -- DNA-Based Diagnostic Tests for Detection and Identification of Biological Weapons -- Concepts for the Development of Immunodiagnostic Assays for Detection and Diagnosis of Biothreat Agents.
520			_aThe release of nerve gas in the Tokyo subways, the spread of biological weapons, and the anthrax attack of 2001 in the United States demonstrate that not only is the threat of such menacing weapons real, but also that we must urgently prepare to deal with future acts of bioterrorism. In Biological Weapons Defense: Infectious Diseases and Counterbioterrorism, prominent experts in biodefense research-many from the US Army Medical Research Institute of Infectious Diseases-authoritatively delineate the universe of scientific, medical, and legal issues facing the biodefense research community. Regarding medical countermeasures and decontamination, the authors review the facts about both the aerosol route of infection and decontamination processes, and fully describe the pathogenesis and treatment of a variety of established pathogens (anthrax, plague, smallpox, Brucellosis, glanders, and Coxiella burnetii). They also examine how to discover the presence of these agents, or other previously unknown biological weapons, and the ongoing efforts to counter such agents, including proteomic and genomic analysis as a gateway to better diagnostics, therapeutics, vaccinations, genotyping, and forensics. Additional chapters discuss the development and use of technology to identify and characterize these infectious organisms and their emerging threats. Comprehensive and authoritative, Biological Weapons Defense: Infectious Diseases and Counterbioterrorism provides researchers, physicians, and policymakers with a sound basis for understanding not only the diseases caused by these infectious organisms, but also an appreciation of the universe of bioterrorism problems that must be mastered to develop effective countermeasures.
590			_aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700	1		_aLebeda, Frank J. _eeditor. _9319785
700	1		_aKorch, George W. _eeditor. _9319786
710	2		_aSpringerLink (Servicio en línea) _9299170
776	0	8	_iEdición impresa: _z9781588291844
856	4	0	_uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1385/1592597645 _zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942			_c14
999			_c289525 _d289525